People · Operator
Named in public records as an officer, director or promoter · active 2021–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Alloy Therapeutics, Inc. | — | Biotechnology | Series C | $116.7M | $736.9M | 2021 |
Jason B. Camm at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jason B. Camm on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Errik B. Anderson | 1 | 5 |
| Jason Coloma | 1 | 3 |
| ULRIK B. NIELSEN | 1 | 2 |
| Piotr B. Bobrowicz | 1 | 1 |
| Logan B. Snyder | 1 | 1 |
| Fabian B. Hansen | 1 | 1 |
| Alex B. Kolicich | 1 | 1 |
| Jay B. Rosanelli | 1 | 1 |
| Anthony B. Sun | 1 | 1 |
| Alaa B. Halawa | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.